Human umbilical cord mesenchymal stem cells inhibit C6 glioma growth via secretion of dickkopf-1 (DKK1)

Molecular and Cellular Biochemistry

Volumn 385, Issue 1-2, 2014, Pages 277-286

  Ma, Shanshan ^a   Liang, Shuo ^a,b   Jiao, Hongliang ^c   Chi, Liankai ^a   Shi, Xinyi ^a   Tian, Yi ^c   Yang, Bo ^c   Guan, Fangxia ^a,d  

^a ZHENGZHOU UNIVERSITY   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^d Henan Academy of Medical Sciences   (China)

Author keywords

DKK1; Glioma; Human umbilical cord; Inhibition; Mesenchymal stem cells

Indexed keywords

ANTIBODY; BETA CATENIN; DICKKOPF 1 PROTEIN; MESSENGER RNA; MYC PROTEIN; SMALL INTERFERING RNA; WNT PROTEIN;

ARTICLE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; PLASMID; PROTEIN EXPRESSION; PROTEIN SECRETION; TUMOR GROWTH; UMBILICAL CORD; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; CULTURE MEDIA, CONDITIONED; GLIOMA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STROMAL CELLS; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UMBILICAL CORD; WNT PROTEINS;

EID: 84890462905     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1836-y     Document Type: Article

References (37)

1. Kang SG, Kim JH, Nam DH, Park K (2005) Clinical and radiological prognostic factors of anaplastic oligodendro glioma treated by combined therapy. Neurol Med Chir 45:232-238
2. Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
3. Desjardins A, Quinn JA, Vredenburgh JJ, Sathornsumetee S, Friedman AH, Herndon JE et al (2007) Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas. J Neurooncol 83:53-60
4. Kang SG, Kim JS, Park K, Kim JS, Groves MD, Nam DH (2006) Combination celecoxib and temozolomide in C6 rat glioma orthotopic model. Oncol Rep 15:7-13
5. Wen PY, Yung WK, Lamborn KR, Dahia PL, Wang Y, Peng B et al (2006) Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clin Cancer Res 12:4899-4907
6. Brower V (2005) Search and destroy: recent research exploits adult stem cells' attraction to cancer. J Natl Cancer Inst 97:414-416
7. Mannello F, Tonti GA, Bagnara GP, Papa S (2006) Role and function of matrix metalloproteinases in the differentiation and biological characterization of mesenchymal stem cells. Stem Cells 24:475-481
8. Laflamme MA, Murry CE (2005) Regenerating the heart. Nat Biotechnol 23:845-856
9. Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II, Nguyen AT et al (2006) Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 203:1235-1247
10. Zhu Y, Sun Z, Han Q, Liao L, Wang J, Bian C, Li J, Yan X, Liu Y, Shao C, Zhao RC (2009) Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK1. Leukemia 23:925-933
11. Qiao L, Xu ZL, Zhao TJ, Ye LH, Zhang XD (2008) DKK1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signaling. Cancer Lett 269:67-77
12. Nakamizo A, Marini F, Amano T (2005) Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65:3307-3318
13. Kang SG, Jeun SS, Lim JY, Kim SM, Yang YS, Oh WI (2008) Cytotoxicity of human umbilical cord blood-derived mesenchymal stem cells against human malignant glioma cells. Childs Nerv Syst 24:293-302
14. Jiao HL, Yang B, Guan FX, Li JB, Song LJ, Hu X, Du Y (2012) Human amniotic membrane derived- mesenchymal stem cells induce C6 glioma apoptosis in vivo through the Bcl-2/caspase pathways. Mol Biol Rep 39:467-473
15. Grobben B, De Deyn PP, Slegers H (2002) Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cancer Tissue Res 310:257-270
16. Yang F, Zeng Q, Yu G, Li S, Wang CY (2006) Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell Signal 18:679-687
17. Baek SH, Kioussi C, Briata P (2003) Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway. Proc Natl Acad Sci USA 100:3245-3250
18. Byun T, Karimi M, Marsh JL (2005) Expression of secreted Wnt antagonists in gastrointestinal tissues: potential role in stem cell homeostasis. J Clin Pathol 58:515-519
19. Mao B, Wu W, Li Y (2001) LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411:321-325
20. Brott BK, Sokol SY (2002) Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins. Mol Cell Biol 22:6100-6110
21. Lu YR, Yuan Y, Wang XJ, Wei LL, Chen YN, Cong C, Li SF, Long D, Tan WD, Mao YQ, Zhang J, Li YP, Cheng JQ (2008) The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Cancer Biol Ther 7:245-251
22. Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C (1998) Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391:357-362
23. Fedi P, Bafico A, Nieto Soria A, Burgess WH, Miki T, Bottaro DP et al (1999) Isolation and biochemical characterization of the human DKK1 homologue, a novel inhibitor of mammalian Wnt signaling. J Biol Chem 274:19465-19472
24. Etheridge SL, Spencer GJ, Heath DJ, Genever PG (2004) Expression profiling and functional analysis of Wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 22:849-860
25. Hall CL, Bafico A, Dai J, Aaronson SA, Keller ET (2005) Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res 65:7554-7560
26. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S et al (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843
27. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103:4619-4621
28. Moon RT, Kohn AD, De Ferrari GV, Kaykas A (2004) Wnt and β-catenin signalling: diseases and therapies. Nat Rev Genet 5:691-701
29. Fodde R, Brabletz T (2007) Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 19:150-158
30. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F (2005) Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105:2821-2827
31. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F et al (2006) Human mesenchymal stem cells modulate B-cell functions. Blood 107:367-372
32. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M (2006) Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24:74-85
33. Ramasamy R, Lam EF, Soeiro I, Tisato V, Bonnet D, Dazzi F (2007) Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 21:304-310
34. Zhu W, Xu W, Jiang R, Qian H, Chen M, Hu J et al (2006) Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol 80:267-274
35. Ma Y, Hao XM, Zhang S, Zhang J (2011) The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells. Breast Cancer Res Treat 80:261-272
36. Qiao L, Xu ZL, Zhao TJ, Zhao ZG, Shi MX, Zhao RC, Ye L, Zhang XD (2008) Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res 18:500-507
37. Studeny M, Marini FC, Dembinski JL (2004) Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96:593-1603